Nakatsu, Japan

Katsuo Arimura

This inventor holds 2 USPTO granted patents. Top assignee: Yoshitomi Pharmaceutical Industries, Ltd.. Active years: 1976-1984.


% Patents Active = 100.0

Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Nakatsu, JA (1976)
  • Oita, JP (1984)

Company Filing History:


Years Active: 1976-1984

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Katsuo Arimura

Introduction

Katsuo Arimura is a notable inventor based in Nakatsu, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that are useful in treating various mental health conditions. With a total of 2 patents to his name, Arimura's work is recognized for its potential impact on drug development.

Latest Patents

Arimura's latest patents include innovative cyclic iminocarboxylic acid derivatives. These compounds, specifically the imidazolido(1,5-c)thiazolidine-3-spiro-4-piperidines, are designed to address conditions such as schizophrenia, mania, and various psychoneuroses. The detailed formula includes various groups that enhance the efficacy of these compounds, making them valuable in the pharmaceutical industry.

Career Highlights

Katsuo Arimura is associated with Yoshitomi Pharmaceutical Industries, Ltd., where he has been instrumental in advancing research and development efforts. His work has contributed to the company's reputation as a leader in pharmaceutical innovation.

Collaborations

Throughout his career, Arimura has collaborated with talented individuals such as Shu Murakami and Taichi Oka. These partnerships have fostered a creative environment that encourages the development of groundbreaking pharmaceutical solutions.

Conclusion

Katsuo Arimura's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work continues to pave the way for advancements in mental health treatments, showcasing the importance of innovation in medicine.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…